Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC2A1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PARG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC441155 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLA2G5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL11RA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPHA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM224A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BMPR1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSEN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPB41L4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VWA3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAP43 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CABP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on